HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chandra, D. Articles by Bhatnagar, A. Search for Related Content PubMed PubMed Citation Articles by Chandra, D. Articles by Bhatnagar, A. Social Bookmarking                What's this?

Nitric Oxide Prevents Aldose Reductase Activation and Sorbitol Accumulation During Diabetes

¹ Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston, Texas
² Division of Cardiology, Department of Medicine, University of Louisville, Louisville, Kentucky

Increased glucose utilization by aldose reductase (AR) has been implicated in the development of diabetes complications. However, the mechanisms that regulate AR during diabetes remain unknown. Herein we report that several nitric oxide (NO) donors prevent ex vivo synthesis of sorbitol in erythrocytes obtained from diabetic or nondiabetic rats. Compared with erythrocytes of nondiabetic rats, the AR activity in the erythrocytes of diabetic rats was less sensitive to inhibition by NO donors or by AR inhibitors—sorbinil or tolrestat. Treatment with N^G-nitro-L-arginine methyl ester (L-NAME), an inhibitor of NO synthesis, enhanced AR activity and sorbitol accumulation in tissues of nondiabetic rats. Application of transdermal nitroglycerin patches or treatment with L-arginine did not inhibit AR activity or sorbitol accumulation in the tissues of nondiabetic animals. Treatment with L-NAME increased, whereas treatment with L-arginine or nitroglycerine patches decreased AR activity and sorbitol content in tissues of diabetic rats. These observations suggest that NO maintains AR in an inactive state and that this repression is relieved in diabetic tissues. Thus, increasing NO availability may be a useful strategy for inhibiting the polyol pathway and preventing the development of diabetes complications.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				Y. Kanetsuna, K. Takahashi, M. Nagata, M. A. Gannon, M. D. Breyer, R. C. Harris, and T. Takahashi Deficiency of Endothelial Nitric-Oxide Synthase Confers Susceptibility to Diabetic Nephropathy in Nephropathy-Resistant Inbred Mice Am. J. Pathol., May 1, 2007; 170(5): 1473 - 1484. [Abstract] [Full Text] [PDF]

				S. Srivastava, K. V. Ramana, R. Tammali, S. K. Srivastava, and A. Bhatnagar Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells. Diabetes, April 1, 2006; 55(4): 901 - 910. [Abstract] [Full Text] [PDF]

				S. K. Srivastava, K. V. Ramana, and A. Bhatnagar Role of Aldose Reductase and Oxidative Damage in Diabetes and the Consequent Potential for Therapeutic Options Endocr. Rev., May 1, 2005; 26(3): 380 - 392. [Abstract] [Full Text] [PDF]

				B. Qin, M. Nagasaki, M. Ren, G. Bajotto, Y. Oshida, and Y. Sato Gosha-jinki-gan (a Herbal Complex) Corrects Abnormal Insulin Signaling Evid. Based Complement. Altern. Med., December 1, 2004; 1(3): 269 - 276. [Abstract] [Full Text] [PDF]

				K. V. Ramana, B. Friedrich, S. Srivastava, A. Bhatnagar, and S. K. Srivastava Activation of Nulcear Factor-{kappa}B by Hyperglycemia in Vascular Smooth Muscle Cells Is Regulated by Aldose Reductase Diabetes, November 1, 2004; 53(11): 2910 - 2920. [Abstract] [Full Text] [PDF]

				A. B. El-Remessy, G. Abou-Mohamed, R. W. Caldwell, and R. B. Caldwell High Glucose-Induced Tyrosine Nitration in Endothelial Cells: Role of eNOS Uncoupling and Aldose Reductase Activation Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3135 - 3143. [Abstract] [Full Text] [PDF]